PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.6631
+0.0209 (3.25%)
At close: Jun 10, 2025, 4:00 PM
0.6800
+0.0169 (2.55%)
After-hours: Jun 10, 2025, 7:57 PM EDT
PAVmed Market Cap
PAVmed has a market cap or net worth of $11.68 million as of June 10, 2025. Its market cap has decreased by -31.28% in one year.
Market Cap
11.68M
Enterprise Value
17.88M
1-Year Change
-31.28%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $11.68M, a decrease of -93.25%. That is a compound annual growth rate of -26.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 11.30M | 63.77% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |